Use of dehydroepiandrosterone to treat primary adrenal insuffici

Details Use of dehydroepiandrosterone to treat primary adrenal insuffici Use of dehydroepiandrosterone to treat primary adrenal insuffici

1997-01-29

1999-01-19

Cook, Rebecca

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

514178, A61K 3156

Patent

active

058613919

ABSTRACT:
The present invention provides a method of treating an individual with primary adrenal insufficiency, comprising the step of administering an effective amount of dehydroepiandrosterone to said individual. Also provided is a method of treating an individual with adrenal failure secondary to dysfunctions of the hypothalamus and/or pituitary gland, comprising the step of administering an effective amount of dehydroepiandrosterone to said individual and a method of treating an individual with adrenal insufficiency due to acquired human immunodeficiency syndrome (AIDS), comprising the step of administering an effective amount of deyhydroepiandrosterone to said individual.

REFERENCES:
Filipponi et al, Archivio per le Scienze Mediche 136(1), 17-24 1979.
Embase Accession No. 94125338, Fujii et al, 1994.
CA 116:51817, Vermeulen et al, 1991.
CA 91: 190917, Filipponi et al, 1979.
Merck Manual, pp. 1050-1054, 1987.

Affiliated with

Also associated with

Rating

Use of dehydroepiandrosterone to treat primary adrenal insuffici does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of dehydroepiandrosterone to treat primary adrenal insuffici, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of dehydroepiandrosterone to treat primary adrenal insuffici will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1246786